CASC9 and esophageal squamous cell carcinoma: Silencing ESCCAL‐1 suppressed ESCC cell invasion, enhanced apoptosis in vitro, and inhibited cancer proliferation by inactivating Src and activating the p38α pathway in the ESCC xenograft mouse model.6, 10